Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Neurology
|
February 25, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J Kuhle, D Leppert, A Petzold, et al.
Plastic and Reconstructive Surgery
|
January 27, 2007
Nontuberculous mycobacterial breast implant infections
Sheina A Macadam, Blair M Mehling, Anne Fanning, et al.
Multiple Sclerosis and Related Disorders
|
July 18, 2018
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
Y Naegelin, M Rasenack, M Andelova, et al.
Neurology
|
October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M Mehling, V Brinkmann, J Antel, et al.
Experimental and Therapeutic Medicine
|
August 13, 2013
A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury
Pu-Cha Jiang, Wen-Ping Xiong, Ge Wang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 7, 2013
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
H Hegen, A Millonig, A Bertolotto, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Neurology
|
February 25, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J Kuhle, D Leppert, A Petzold, et al.
Plastic and Reconstructive Surgery
|
January 27, 2007
Nontuberculous mycobacterial breast implant infections
Sheina A Macadam, Blair M Mehling, Anne Fanning, et al.
Multiple Sclerosis and Related Disorders
|
July 18, 2018
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis
Y Naegelin, M Rasenack, M Andelova, et al.
Neurology
|
October 15, 2008
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M Mehling, V Brinkmann, J Antel, et al.
Experimental and Therapeutic Medicine
|
August 13, 2013
A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury
Pu-Cha Jiang, Wen-Ping Xiong, Ge Wang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 7, 2013
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development
H Hegen, A Millonig, A Bertolotto, et al.
Page
of 3